JOHNSON & JOHNSON (JNJ) Insider Transactions
JNJ Insider Buying & Selling Activity
Between Aug 15, 2025 and Aug 17, 2026, 12 insiders at JOHNSON & JOHNSON (JNJ) reported 26 transactions on record: 1 purchase and 25 sales. In total, insiders bought $257.7K and sold $181.82M, a net selling position of $181.57M. 4 insiders also sold within a 30-day window around Aug 17, 2026.
Multiple insiders trading the same direction in a short window is generally read as a stronger signal than any single trade alone.
| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sale | 123.3K | $32.20M |
| Aug 22, 2025 | Duato Joaquin | CEO and Chairman of the Board | Sale | 125.8K | $22.55M |
| Jan 26, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sale | 100.0K | $22.12M |
| Feb 17, 2026 | Wolk Joseph J | Exec VP, CFO | Sale | 89.7K | $21.77M |
| Feb 17, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 53.9K | $13.11M |
Every insider with activity on record, most recently active first.
| Insider | Role | Last Activity | Date | Latest Known Holding |
|---|---|---|---|---|
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sale | Aug 17, 2026 | 194.5K |
| Duato Joaquin | CEO and Chairman of the Board | Sale | Aug 13, 2026 | 276.0K |
| Forminard Elizabeth | EVP, Chief Legal Officer | Sale | Aug 6, 2026 | 17.0K |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Sale | Jul 20, 2026 | 23.0K |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sale | Jun 11, 2026 | 114.3K |
| Decker Robert J | VP Corporate Controller | Sale | Feb 27, 2026 | 23.7K |
| Schmid Timothy | EVP, WW Chair, MedTech | Sale | Feb 20, 2026 | 25.4K |
| Wolk Joseph J | Exec VP, CFO | Sale | Feb 17, 2026 | 14.0K |
| REED JOHN C | EVP, Innovative Medicine, R&D | Sale | Feb 17, 2026 | 10.7K |
| Swanson James D. | EVP, CIO | Sale | Feb 17, 2026 | 25.7K |
| JOHNSON & JOHNSON | 10% Owner | Sale | Nov 26, 2025 | 4.04M |
| MORIKIS JOHN G | Director | Purchase | Nov 26, 2025 | 1.8K |
Every purchase and sale on record, deduplicated. "52w range" shows where that price sat in the trailing year at the time, and "Since" shows the paper return from that price to today.
| Date | Insider | Role | Type | Shares | Price | Value | 52w Range | Since |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sale | 15.0K | $263.36 | $3.95M | 95% | +1.8% |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sale | 123.3K | $261.17 | $32.20M | 95% | +2.6% |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | Sale | 15.9K | $257.00 | $4.09M | 89% | +4.3% |
| Aug 5, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sale | 48.5K | $258.15 | $12.52M | 90% | +3.8% |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sale | 23.1K | $251.27 | $5.79M | 82% | +6.7% |
| Jun 11, 2026 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sale | 10.0K | $241.15 | $2.41M | 90% | +11.2% |
| Feb 27, 2026 | Decker Robert J | VP Corporate Controller | Sale | 4.1K | $247.87 | $1.01M | 100% | +8.1% |
| Feb 20, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Sale | 1.3K | $245.66 | $324.8K | 96% | +9.1% |
| Feb 18, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Sale | 22.6K | $244.33 | $5.53M | 100% | +9.7% |
| Feb 17, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sale | 6.2K | $243.39 | $1.51M | 99% | +10.1% |
| Feb 17, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 53.9K | $243.00 | $13.11M | 99% | +10.3% |
| Feb 17, 2026 | Wolk Joseph J | Exec VP, CFO | Sale | 89.7K | $242.80 | $21.77M | 99% | +10.4% |
| Feb 17, 2026 | Swanson James D. | EVP, CIO | Sale | 20.5K | $242.70 | $4.98M | 99% | +10.4% |
| Feb 13, 2026 | Swanson James D. | EVP, CIO | Sale | 41.6K | $243.73 | $10.13M | 99% | +10.0% |
| Jan 26, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sale | 100.0K | $221.23 | $22.12M | 100% | +21.2% |
| Nov 26, 2025 | JOHNSON & JOHNSON | 10% Owner | Sale | 6.3K | $10.03 | $63.6K | 100% | +2572.4% |
| Nov 26, 2025 | MORIKIS JOHN G | Director | Purchase | 1.3K | $206.15 | $257.7K | 100% | +30.0% |
| Nov 24, 2025 | JOHNSON & JOHNSON | 10% Owner | Sale | 2.2K | $10.06 | $22.1K | 100% | +2564.4% |
| Nov 21, 2025 | JOHNSON & JOHNSON | 10% Owner | Sale | 500 | $10.00 | $5.0K | 100% | +2580.4% |
| Nov 12, 2025 | JOHNSON & JOHNSON | 10% Owner | Sale | 1.0K | $10.00 | $10.0K | 100% | +2580.4% |
| Nov 7, 2025 | JOHNSON & JOHNSON | 10% Owner | Sale | 200 | $10.00 | $2.0K | 86% | +2580.4% |
| Nov 6, 2025 | JOHNSON & JOHNSON | 10% Owner | Sale | 52.3K | $10.21 | $534.3K | 87% | +2525.3% |
| Oct 17, 2025 | REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 21.7K | $192.71 | $4.19M | 100% | +39.1% |
| Sep 4, 2025 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sale | 56.5K | $177.81 | $10.04M | 99% | +50.7% |
| Aug 22, 2025 | Duato Joaquin | CEO and Chairman of the Board | Sale | 125.8K | $179.21 | $22.55M | 100% | +49.6% |
| Aug 15, 2025 | Wolk Joseph J | Exec VP, CFO | Sale | 16.8K | $176.91 | $2.98M | 100% | +51.5% |
52w range and paper return are only computed for transactions with a date that lines up with price history on record.
Are insiders buying or selling JNJ stock?
On record between Aug 15, 2025 and Aug 17, 2026, JOHNSON & JOHNSON insiders made 1 purchase ($257.7K) and 25 sales ($181.82M), a net selling position of $181.57M.
Has there been cluster buying or selling at JNJ?
No buying clusters (2+ insiders within 30 days) on record. 3 insiders sold within 30 days around Sep 4, 2025; 2 insiders sold within 30 days around Nov 12, 2025; 6 insiders sold within 30 days around Feb 20, 2026; 4 insiders sold within 30 days around Aug 17, 2026.
What is the largest recent insider transaction at JNJ?
The largest transaction on record is Duato Joaquin (CEO and Chairman of the Board), a sale of $32.20M on Aug 13, 2026.
Does a 10b5-1 automatic trading plan explain JNJ's insider sales?
This data does not indicate whether a given sale was part of a pre-scheduled Rule 10b5-1 plan, that detail is not captured in the transaction data available here.